EXACT Therapeutics AS Awarded NOK 7.4 M Grant for the Development of its Next Generation Ultrasound Transducer and Navigation System for ACT®

/in

OSLO/ LONDON: 21 December 2021: EXACT Therapeutics AS (“EXACT-Tx” or “the Company”, Euronext Growth: EXTX), a clinical-stage precision health company developing the Acoustic Cluster Therapy (ACT®), a proprietary ultrasound-mediated drug delivery platform to enhance the efficacy of therapies across multiple diseases, today announces the award of a research and innovation grant from the Norwegian Research […]

Read more

Merck Acquires Chord Therapeutics to Expand Neuroinflammatory Pipeline

/in

Chord Therapeutics was launched by Omega Funds in October 2020 to develop new oral treatments for rare neuroinflammatory diseases Merck to accelerate development of Chord’s innovative pipeline for generalized Myasthenia Gravis (gMG) and Neuromyelitis Optica Spectrum Disorder (NMOSD) ‍Focused expansion in neuroinflammatory diseases builds on Merck’s existing neurology portfolio in Multiple Sclerosis (MS)  Geneva, December […]

Read more

Futura provides US regulatory and commercial update for MED3000

/in

Futura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products for sexual health and pain relief, is pleased to provide an update on good progress with its regulatory and commercial activities for MED3000. MED3000 is the Company’s breakthrough, topical gel formulation for treatment of erectile dysfunction (“ED”).  It has the potential […]

Read more

Verona Pharma Reports TQT Study Successfully Demonstrated No Clinically Relevant Effect on Cardiac Conduction

/in

Study Supports Ongoing Phase 3 Program and Planned NDA Submission LONDON and RALEIGH, N.C., Dec. 16, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, today announces ensifentrine met all safety objectives in a thorough QT (“TQT”) study designed to evaluate effects, if any, of […]

Read more

Novo Nordisk Fonden: New international research center to drive future stem cell-derived medicines

/in

Stem cell medicine is delivering hope for new treatments across many currently untreatable diseases. Stem cells are found throughout the human body and are critical for a healthy life. Recent scientific advances now allow us to identify, isolate and engineer stem cells to create human tissue models, repair injured tissues and in the future grow […]

Read more
© Optimum Strategic Communications.